BGI Genomics Co (SZSE:300676) Ending Cash Position : ¥2,911 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Ending Cash Position?

BGI Genomics Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥2,911 Mil.

BGI Genomics Co's quarterly Ending Cash Position declined from Sep. 2023 (¥5,095 Mil) to Dec. 2023 (¥3,555 Mil) and declined from Dec. 2023 (¥3,555 Mil) to Mar. 2024 (¥2,911 Mil).

BGI Genomics Co's annual Ending Cash Position declined from Dec. 2021 (¥6,492 Mil) to Dec. 2022 (¥5,131 Mil) and declined from Dec. 2022 (¥5,131 Mil) to Dec. 2023 (¥3,555 Mil).

BGI Genomics Co Ending Cash Position Historical Data

The historical data trend for BGI Genomics Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Ending Cash Position Chart

BGI Genomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

725.48

5,410.06

6,491.54

5,131.17

3,555.14

BGI Genomics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															5,304.95	5,006.76	5,095.09	3,555.14	2,910.90

BGI Genomics Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BGI Genomics Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5131.174	+	-1576.033
	=	3,555

BGI Genomics Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3555.14	+	-644.241
	=	2,911

BGI Genomics Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BGI Genomics Co (SZSE:300676) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083

Website

http://www.bgi.com

BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.

Executives

Wang Jian	Director
Liu Na	Executives
Sun Ying Jun	Director
Yin Ye	Directors, executives
Du Yu Tao	Directors, executives
Li Song Gang	Supervisors
Hu Yu Jie	Supervisors
Xu Qian	Secretary Dong
Li Zhi Ping	Executives
Chen Yi Qing	Executives
Li Wen Qi	Supervisors

BGI Genomics Co (SZSE:300676) Headlines

No Headlines